Microcystin Detection and Analysis

Comprehensive Microcystin Detection and Analysis Services – Advanced LC‑MS/MS, ELISA, and Adda‑Specific Assays for Regulatory Compliance and Risk Assessment

The reliable and sensitive detection of microcystins – a family of hepatotoxic cyclic peptides produced by cyanobacteria – is an essential requirement for drinking water safety, recreational water monitoring, food safety (particularly in seafood and dietary supplements), and environmental risk assessment. Microcystins, with over 250 known variants, pose a significant threat to human and animal health through acute liver toxicity and tumour promotion. Regulatory bodies including the WHO, US EPA, and EU have established guideline values (typically 1 µg/L for MC‑LR equivalents in drinking water) that necessitate rigorous, validated analytical methods. However, a robust microcystin testing strategy is not a simple “screening” exercise; it requires a sophisticated, multi‑method approach that integrates high‑performance liquid chromatography‑tandem mass spectrometry (LC‑MS/MS) for confirmatory quantification, enzyme‑linked immunosorbent assay (ELISA) for rapid screening, and protein phosphatase inhibition assay (PPIA) for toxicity‑equivalent measurement. The choice of method must account for the diverse chemical nature of microcystin congeners, the matrix complexity (water, algal bloom material, fish, shellfish, supplements), the required sensitivity (sub‑µg/L levels), and the need for total microcystin quantification or congener‑specific profiling. A poorly designed analytical protocol can lead to underestimation of total toxicity, false‑negative results for low‑level contamination, or failure to detect emerging variants, compromising public health and regulatory compliance. Our ISO/IEC 17025‑accredited and GMP‑compliant laboratory offers a fully integrated microcystin testing platform, covering the entire spectrum from rapid screening and congener‑specific quantification to total toxicity assessment and unknown metabolite identification. We deliver quantitative, traceable results, with full method validation, strict quality control, and expert interpretation, enabling you to safeguard water supplies, ensure product safety, and meet the most stringent regulatory requirements with confidence.

1. The Scientific and Regulatory Imperative for Microcystin Testing

Microcystins are produced by cyanobacteria such as Microcystis, Planktothrix, and Dolichospermum during harmful algal blooms (HABs). Their primary toxicological action is the inhibition of protein phosphatases 1 and 2A, leading to liver damage and, in chronic exposure, liver tumour promotion. The most common and toxic congener, microcystin‑LR (MC‑LR), is the reference for guideline values, but the presence of other variants (MC‑RR, MC‑YR, MC‑LA, MC‑LY, etc.) – which may have similar or even higher toxicity – necessitates comprehensive analytical coverage. Regulatory limits are stringent: the WHO provisional guideline for drinking water is 1 µg/L for MC‑LR equivalents; the US EPA has a health advisory at 0.3 µg/L for MC‑LR and 1.6 µg/L for total microcystins (for children); and many countries have established action levels for recreational waters. Monitoring requirements extend to fish, shellfish, and dietary supplements (e.g., blue‑green algae products) where microcystins can accumulate. The choice of analytical approach – whether ELISA (for rapid screening), PPIA (for toxicity‑based quantification), or LC‑MS/MS (for confirmatory congener‑specific analysis) – must be guided by the sample matrix, the required sensitivity, and the regulatory decision point. Our service begins with a comprehensive consultation to define the optimal testing strategy for your specific water source, product, or risk assessment objective, ensuring both scientific rigour and regulatory compliance.

2. Our Comprehensive Microcystin Testing Platform – Multi‑Technology, Multi‑Matrix

We maintain a complete suite of validated microcystin testing methods, all performed in a dedicated analytical facility with stringent quality controls, and using certified reference materials (e.g., from the National Research Council Canada, or commercially available CRM) and stable isotope‑labelled internal standards for accurate quantification. Our portfolio includes:

2.1 Liquid Chromatography‑Tandem Mass Spectrometry (LC‑MS/MS) – Gold Standard for Congener‑Specific Quantification
We perform LC‑MS/MS using state‑of‑the‑art triple quadrupole and high‑resolution mass spectrometers (e.g., Sciex 6500+, Waters Xevo TQ‑XS, or Orbitrap systems) operating in multiple reaction monitoring (MRM) or full‑scan high‑resolution mode. We have developed and validated multi‑residue methods that cover over 15 major microcystin congeners (MC‑LR, MC‑RR, MC‑YR, MC‑LA, MC‑LY, MC‑LW, MC‑LF, MC‑WR, MC‑DM, MC‑HilR, MC‑HtyR, and others). The method includes solid‑phase extraction (SPE) or rapid on‑line SPE for water samples, and dedicated extraction and clean‑up protocols for algal material, fish, shellfish, and dietary supplements. We achieve limits of quantification (LOQs) well below 0.05 µg/L for water, and sub‑ppb levels for solid matrices, with full validation according to EU Decision 2002/657/EC or FDA guidance. We use isotope‑dilution with ¹³C‑ or ²H‑labelled internal standards (e.g., ¹³C‑MC‑LR) to correct for matrix effects and extraction losses, ensuring the highest accuracy and precision. We provide congener‑specific concentrations and, when required, the calculated total microcystin equivalents based on the toxicity equivalency factors (TEFs) for each congener.

2.2 Enzyme‑Linked Immunosorbent Assay (ELISA) – Rapid Screening and Semi‑Quantitative Assessment
For high‑throughput screening and for initial risk assessment, we perform ELISA using commercially available and in‑house validated kits (e.g., Abraxis, Beacon, or Eurofins). Our ELISA methods are calibrated against MC‑LR and provide a total microcystin concentration (in MC‑LR equivalents) with a detection limit typically below 0.1 µg/L. This method is ideal for field screening, for monitoring dynamic changes in bloom events, and for reducing the number of confirmatory analyses. All positive ELISA results are confirmed by LC‑MS/MS to eliminate false positives due to cross‑reactivity with other cyanotoxins or matrix interferences.

2.3 Protein Phosphatase Inhibition Assay (PPIA) – Toxicity‑Equivalent Activity Measurement
For applications that require a direct measure of the biological toxicity (e.g., drinking water compliance or health‑risk assessment), we perform the PPIA using a validated colorimetric or fluorometric format. The PPIA measures the total inhibitory activity of microcystins (and nodularins) against protein phosphatase 2A, providing a toxicity‑equivalent concentration (TEC) in MC‑LR equivalents that is independent of the congener profile. This method is particularly useful when the congener composition is unknown or when the toxicity of the mixture is the primary concern. We correlate the PPIA results with the LC‑MS/MS data to provide a comprehensive picture of both the chemical concentration and the biological potency.

2.4 Adda‑Specific and Total Microcystin Determination – Chemical and Spectrophotometric Methods
For rapid screening or when instrumentation is limited, we also offer Adda‑specific ELISA (targeting the unique Adda amino acid moiety present in all microcystins) and total microcystin measurement by HPLC‑UV after oxidative cleavage of the Adda group (using the MMPB method, or 2‑methyl‑3‑methoxy‑4‑phenylbutanoic acid). While these methods are less sensitive and less specific than LC‑MS/MS, they serve as useful tools for preliminary assessment and for laboratories with limited resources. Our laboratory uses these only as supplementary techniques, with LC‑MS/MS as the definitive confirmatory method.

2.5 Sample Preparation and Matrix‑Specific Protocols – Optimised for Water, Algae, Fish, and Supplements
We employ validated sample preparation protocols that are optimised for each matrix. For water samples, we use solid‑phase extraction (SPE) with C18 or polymeric sorbents, followed by elution and concentration. For algal bloom material (cyanobacterial scum), we use freeze‑thaw or ultrasonication extraction with aqueous methanol or acetonitrile. For fish and shellfish (muscle, hepatopancreas), we use solvent extraction with defatting steps and SPE clean‑up. For dietary supplements (e.g., spirulina, Aphanizomenon flos‑aquae), we use extraction with methanol/water and, if necessary, additional clean‑up with immunoaffinity columns to remove matrix interferences. We ensure that each method is validated for recovery (typically > 80%), reproducibility (RSD < 15%), and stability, and we include internal standards to correct for all losses.

2.6 Multi‑Toxin Screening – Co‑Detection of Other Cyanotoxins
In addition to microcystins, our LC‑MS/MS platform can simultaneously detect and quantify other cyanotoxins, including nodularins, cylindrospermopsin, anatoxin‑a, homoanatoxin‑a, saxitoxin, and β‑methylamino‑L‑alanine (BMAA). This is essential for comprehensive monitoring of harmful algal blooms and for risk assessment in multi‑toxin environments. We provide a full report of all detected cyanotoxins, with individual concentrations and toxicity equivalents where relevant.

2.7 Method Validation and Regulatory Compliance – Full Documentation
We provide full method validation for your microcystin testing protocol, including: (a) selectivity (against a panel of other cyanotoxins and common interferences); (b) linearity (over the expected concentration range); (c) accuracy (by spike‑and‑recovery experiments at multiple levels); (d) precision (intra‑assay, inter‑assay, and inter‑operator); (e) limit of detection (LOD) and limit of quantification (LOQ); (f) matrix effects (evaluated by post‑column infusion or by comparing standards in solvent vs. matrix); and (g) stability (bench‑top, freeze‑thaw, long‑term). The validation report is structured to meet the requirements of the US EPA, EU, WHO, or other regulatory authorities.

3. Advanced Capabilities – Metabolite Profiling, Unknown Identification, and Customised Studies

For clients requiring a deeper level of characterisation or a high‑level validation of their testing programme, we offer a suite of customised, research‑grade services that go beyond routine residue analysis:

3.1 Untargeted Screening and Metabolite Profiling – Detection of Emerging Microcystin Variants and Degradation Products
We use high‑resolution mass spectrometry (HRMS) with full‑scan and data‑dependent acquisition (DDA) to perform untargeted screening for unknown microcystin congeners, degradation products (e.g., linearized microcystins, oxidized products), and other cyanobacterial metabolites. Our in‑house database and processing workflows (using Compound Discoverer, MZmine, or similar) allow us to tentatively identify new compounds and to provide a comprehensive chemical profile of your sample. This service is essential for monitoring the transformation of microcystins during water treatment, for studying the fate of toxins in the environment, and for supporting regulatory decision‑making on emerging risks.

3.2 Stable Isotope Dilution – Accurate Quantification with Multiple Internal Standards
For the highest accuracy in quantification, we use stable isotope‑labelled internal standards (e.g., ¹³C‑MC‑LR, ¹³C‑MC‑RR, ²H‑MC‑YR) for each major congener, and for total microcystin determination, we use a labelled surrogate such as ¹³C‑Adda. This method corrects for all losses during extraction, clean‑up, and ionisation, and provides the lowest possible measurement uncertainty (typically < 5% RSD). We recommend this approach for regulatory compliance studies and for critical risk assessments.

3.3 Degradation and Transformation Studies – Stability in Water Treatment and Environmental Matrices
We can conduct degradation studies to assess the fate of microcystins under different conditions (e.g., chlorination, ozonation, UV irradiation, photocatalysis, or biological degradation). We monitor the disappearance of parent microcystins and the formation of transformation products, using a combination of LC‑MS/MS and HRMS. We provide kinetic data (half‑life, degradation rate constants) and a full identification of the major transformation products, helping you to evaluate the effectiveness of water treatment processes and to understand the potential risks of transformation products.

3.4 Toxicological Equivalence (TEF) Assessment – Customised Risk Modelling
We can apply quantitative structure‑activity relationship (QSAR) models and our own in‑vitro toxicity data (PPIA) to derive a toxicity equivalency factor (TEF) for the microcystin congeners present in your sample, providing a more refined risk assessment than the standard WHO TEFs. This service is particularly useful for samples containing multiple congeners with uncharacterised toxicity.

3.5 Method Development for Novel Matrices – Tailored to Your Product
We develop and validate custom methods for microcystin analysis in non‑standard matrices (e.g., food supplements, cosmetics, plant tissues, or complex industrial matrices). We work with you to optimise the extraction, clean‑up, and detection conditions, and we provide a full validation report that is directly usable for regulatory submissions or for internal quality assurance.

3.6 Data Review and Regulatory Submission Support
Our team of experienced environmental chemists and regulatory specialists can assist you in the interpretation of the results, in the preparation of the required documentation for regulatory submissions (e.g., for EPA registration, WHO compliance, or EU monitoring reports), and in responding to queries from authorities. We provide a full data package, including the raw chromatograms, the calibration curves, the QC data, and the uncertainty budgets.

4. Data Quality, Standardisation, and Comprehensive Reporting

All analyses are conducted under a strict quality management system that includes the use of certified reference materials, routine system suitability tests, and participation in proficiency testing schemes (e.g., the EPA’s Cyanobacteria Assessment Network, and the EU‑RL PTs for cyanotoxins). Our reports provide:

• Full method description – detailing the sample preparation, the chromatographic conditions, the MS parameters, and the data processing.
• Detailed results – including the congener‑specific concentrations (µg/L or µg/kg), the total microcystin concentration (either by sum of congeners or by ELISA/PPIA), the toxicity‑equivalent concentration (if applicable), and the expanded measurement uncertainty (k=2).
• Quality control data – including the recovery rates, the RSD of replicates, and the results of the QC samples, confirming the validity of the run.
• Graphical outputs – including chromatograms, calibration curves, and, where applicable, mass spectra of the identified compounds.
• Interpretative comments – by our senior environmental chemists, providing a clear statement on the compliance with the relevant regulations, the potential health risks, and any recommendations for further action.

Our reports are structured to meet the requirements of regulatory audits, customer inspections, and internal quality assurance.

Turnaround times: 3‑5 working days for routine LC‑MS/MS screening, 1‑2 working days for ELISA screening, and 1‑2 weeks for method development or advanced profiling. Express services are available for urgent cases.

5. Why Choose Our Laboratory for Microcystin Testing

We are one of the few laboratories that hold ISO/IEC 17025 accreditation and GMP compliance for microcystin testing, covering all major congeners and matrices, using both LC‑MS/MS and ELISA/PPIA. Our integrated infrastructure combines state‑of‑the‑art LC‑MS/MS and HRMS platforms, automated sample preparation systems, and a dedicated data analysis unit – enabling cross‑verification of results and a comprehensive coverage of the cyanotoxin profile. Our team comprises PhD‑level analytical chemists, environmental toxicologists, and regulatory specialists with extensive experience in method development, validation, and regulatory submissions, and we have a proven track record of supporting water utilities, food producers, and environmental agencies.

We offer unparalleled flexibility: we accept all types of samples – drinking water, surface water, cyanobacterial scum, fish, shellfish, dietary supplements, and even complex food products – and we provide customised testing panels that cover your specific congener list and regulatory requirements. Our secure online portal enables real‑time tracking, access to raw data, and downloadable certificates of analysis.

Our modular pricing ensures cost‑effectiveness: you select the level of analysis – from a simple ELISA screening to a full congener‑specific LC‑MS/MS quantification and toxicity assessment – with discounts for routine monitoring programmes and bulk submissions. We also provide training, method transfer, and technical consultancy to help you build or strengthen your internal microcystin testing capabilities.

With a proven history of serving over 70 clients in the water, food, and environmental sectors, we have enabled our partners to achieve regulatory compliance, protect public health, and manage cyanobacterial risks effectively. We invite you to leverage our expertise for your microcystin testing needs.

Contact our technical experts today to discuss your sample type, target congeners, and specific regulatory or risk‑assessment objectives. We will design a tailored testing plan and provide a detailed proposal within one business day.